Could faulty stem cells in the airways drive a rare lung disease? a study aims to find out.
NCT ID NCT07018804
First seen Jul 29, 2026 · Last updated Jul 30, 2026 · Updated 1 time
Summary
This study explores whether stem cell dysfunction in the small airways causes bronchiolitis obliterans syndrome (BOS), a serious lung condition that can occur after a stem cell transplant. Researchers will collect airway cells from people with BOS and healthy volunteers to compare how these cells behave. The goal is to uncover the root cause of BOS and identify potential targets for future treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- bronchoscopic brushing, single-cell cloning, cell function identification
- What this could lead to
- If the link between stem cell dysfunction and BOS is confirmed, this could point toward targeted therapies that repair airway damage and improve outcomes.
- What could go wrong
- This is an early experimental study with lab and animal models, not a treatment trial. Findings may not translate to humans or lead to a therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRONCHIOLITIS OBLITERANS SYNDROME (BOS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Haikou Affiliated Hospital of Central South University Xiangya School of Medicine
Haikou, Hainan, 570208, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.